Form D · Pharmaceuticals
Nevakar Inc.
Bridgewater, NJ · CIK 0001677308
Offering snapshot reported Aug 8, 2023 · SEC filing
- Reported sold
- $4.59M Offering amount: $12M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 24, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 8, 2023 | Initial | $4,585,000 | No comparison | 12 | SEC filing |
| Jun 30, 2016 | Initial | $11,502,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-489081
The securities offered are units consisting of common stock and warrants, with each unit consisting of one share of common stock of the issuer and a warrant to purchase 0.25 of a share of common stock of the issuer.
Source: Form D, filed Aug 8, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ram Potti | Director |
| Navneet Puri | Director, Executive |
| Sri Ramanathan | Executive |
| Alex Sisson | Director |
| Raul Trillo | Director, Executive |
| Ron Wooten | Director |
| George Zorich | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1019 Us Highway 202 206, Building K New Jersey Center Of Excellence
Bridgewater, NJ, 08807
Bridgewater, NJ, 08807